Abstract
Reduction of imatinib dose and persistence of complete molecular response after p210 multipeptide vaccine in chronic myeloid leukaemia treated with dose escalation for acquired resistance
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have